Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-19
2011-07-19
Desai, Rita J (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07982041
ABSTRACT:
A compound having the formulain racemic form, enantiomerically enriched form or enantiomerically pure form, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 5428166 (1995-06-01), Comins
patent: 5468859 (1995-11-01), Fortunak
patent: 5700939 (1997-12-01), Fortunak
patent: 5744605 (1998-04-01), Curran
patent: 5910491 (1999-06-01), Hausheer
patent: 5935967 (1999-08-01), Hausheer
patent: 5981542 (1999-11-01), Bigg
patent: 6057303 (2000-05-01), Haridas
patent: 6136978 (2000-10-01), Curran
patent: 6150343 (2000-11-01), Curran
patent: 7220860 (2007-05-01), Curran et al.
patent: 9529917 (1995-09-01), None
patent: 97/00876 (1997-01-01), None
patent: 98/07727 (1998-02-01), None
patent: 98/28304 (1998-07-01), None
patent: 98/28305 (1998-07-01), None
patent: 98/35940 (1998-08-01), None
patent: 99/11646 (1999-03-01), None
patent: 00/50427 (2000-08-01), None
patent: 00/61146 (2000-10-01), None
Curran et al , 1995, Cascade Radical reactions of Isonitriles.
Josein Hubert et al , A general synthetic approarch to (20S)-Camptothecin Family of Antitumor agents, 1998.
Curran, D.P. and Liu, H., “New 4+1 Radical Annulations—A Formal Total Synthesis of (+/−)-Camptothecin,” J. Am. Chem Soc., 114, 5863-5864 (1992). Published Jul. 1, 1992.
Curran, D.P., “The Camptothecins—A reborn Family of Antitumor Agents”, J. Chin. Chem. Soc., 40, 1-6 (1993). Published Feb. 1993.
Curran, D.P. et al., “Recent Applications of Radical Reactions in Natural Product Synthesis,” Pure Appl. Chem., 65, 1153-1159 (1993). Published Jun. 1993.
Curran, D.P. et al., “Cascade Radical Reactions of Isonitriles: A Second-Generation Synthesis of (20S)-Camptothecin, Topotecan, Irinotecan, and GI-147211C,” Angew. Chem. Int. Ed, 34, 2683-2684 (1995). Published Jan. 5, 1996.
Curran, D.P., Liu, H.; Josien, H; Ko, S.B., “Tandem Radical Reactions of Isonitriles with 2-pyrdonyl and other aryl radicals: Scope and Limitations, and a First Generation Sunthesis of (+/−)-Camptothecin,” Tetrahedron, 52, 11385-11404 (1996). Published Aug. 1996.
Josien, H. et al., “Synthesis of (S)-mappicine and Mappicine Ketone Via Radical Cascade Reaction of Isonitirles,” Tetrahedron, 53, 8881-8886 (1997). Published Jun. 30, 1997.
Josien, H. et al., “7-Silylcamptothecins (Silatecans): A New Family of Camptothecin Antitumor Agents,” Bioorg. Med. Chem. Lett. 7, 3189-3295 (1997).
Josien, H. et al., “A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl Isonitriles,” Chem. Eur. J. 4, 67-83 (1998). Published Jan. 1998.
Zihou, M. et al., “Reduced Albumin Binding Promotes the Stability and Activity of Topotecan in Human Blood,” Biochemistry, 34, 13722-13727 (1995).
Burke, T.G. and Zihou, M., “The Structural Basis of Camptothecin Interaction with Human Serum Albumin: Impact on Drug Stability,” J. Med. Chemistry, 37, 40-46 (1994).
Zihou, M. and Burke, T.G., “Marked Interspecies Variations Concerning the Interactions of Camptothecin with Serum Albumins: A Frequency-Domain fluorescence Spectroscopic Study,” Biochemistry, 33, 12540-12545 (1994).
Zihou, M. and Burke, T.G., “Differential Interactions of Camptothecin Lactone and Carboxylate Forms with Human Blood Components,” Biochemistry, 33, 10325-10336 (1994).
Burke, T.G., and Zihou, M., “Ethyl Substitution at the 7 Position Extends the Half-Life of 10-Hydroxycamptothecin in the Presence of Human Serum Albumin,” J. Med. Chemistry, 37:17, 2580-2582 (1993).
Burke, T.G. et al., “Lipid Bilayer Partitioning and Stability of Camptothecin Drugs,” Biochemistry, 32:20, 5352-5364 (1993).
Zihou, M. and Burke, T.G., Preferential Binding of the Carboxylate Form of Camptothecin by Human Serum Albumin, Anal. Biochem., 212, 285-287 (1993).
Burke, T.G. and Tritton, T.R., “Structural Basis of Anthracycline Selectivity for Unilamellar Phosphatidylcholine Vesicles: An Equilibrium Binding Study,” Biochemistry, 24, 1768-1776 (1985).
Burke, T.G. and Tritton, T.R., “Location and Dynamics of Anthracycline Bound to Unilamellar Phosphatidylcholine Vesicles,” Biochemistry, 24, 5972-5980 (1985).
Burke, T.G. et al., “The Important Role of Albumin in Determining the Relative Human Blood Stabilities of the Camptothecin Anticancer Drugs,” J. Parm. Sciences, 84:4 (1995).
Bom et al.; Novel A,B,E-ring Modified Camptothecins Displaying High Lipophilicity and Markedly Improved Human Blood Stabilities; Med. Chem.; Aug. 1999; vol. 42; No. 16; pp. 3018-3022.
Lavergne, Olivier et al.; Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues; J. Med. Chem, 1998; 41; pp. 5410-5419.
Bom David
Burke Thomas G.
Curran Dennis P.
Bartony & Associates LLC
Desai Rita J
University of Kentucky Research Foundation
University of Pittsburgh-of the Commonwealth System of Higher Ed
LandOfFree
Camptothecin analogs and methods of preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Camptothecin analogs and methods of preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camptothecin analogs and methods of preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626878